<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01924481</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00023752</org_study_id>
    <nct_id>NCT01924481</nct_id>
  </id_info>
  <brief_title>Effects of a Cocoa Shot on the Human Brain</brief_title>
  <official_title>Effects of a Cocoa Shot on the Human Brain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Hershey Company</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Hershey Company is interested in investigating the effects of various chocolate beverages
      on brain physiology and cognitive function. The main substances in the drinks that are known
      to influence the brain are caffeine (and related chemicals such as theobromine) and
      flavonoids. Flavonoids are chemical found in plants and are most commonly associated with
      antioxidant activity. Caffeine, chemicals related to caffeine, and flavonoids are all
      naturally occurring and all potentially alter brain physiology. This study will evaluate
      changes in brain blood flow and cognition following the consumption of drinks with various
      combinations of the Primary Ingredients. Caffeine is likely to have peak effects within
      1-hour of ingesting the chocolate while the flavonoids are likely to have peak effects 3-4
      hours after ingestion. The study proposed here will evaluate ingredients in a 4-arm
      cross-over double-blind design in an attempt to understand the differential effects of these
      compounds in chocolate drinks.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Working Memory (% correct)</measure>
    <time_frame>before, 1 hour and 3 hours post beverage</time_frame>
    <description>N-Back Task</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Response Time (milliseconds)</measure>
    <time_frame>before, 1 hour and 3 hours post beverage</time_frame>
    <description>Simple Response Time Task</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Short Term Memory (# correct)</measure>
    <time_frame>before, 1 hour and 3 hours post beverage</time_frame>
    <description>Hopkins Verbal Learning Task (HVLT)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Mood (change in Likert scale score)</measure>
    <time_frame>before, 1 hour and 3 hours post beverage</time_frame>
    <description>Profile of Mood Status(POMS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Attention (% accuracy)</measure>
    <time_frame>before, 1 hour and 3 hours post beverage</time_frame>
    <description>Eriksen Flanker Task</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Executive Function (# correct)</measure>
    <time_frame>before, 1 hour and 3 hours post beverage</time_frame>
    <description>Stroop Task</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Brain Blood Flow (ml/g/min)</measure>
    <time_frame>1 hour and 3 hours post beverage</time_frame>
    <description>Non-invasive brain perfusion measured with arterial spin labeling magnetic resonance imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>% Change in Heart Rate (beats/minute)</measure>
    <time_frame>before, 1 hour and 3 hours post beverage</time_frame>
    <description>pulse</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>% Change in Respiration (breaths/minute)</measure>
    <time_frame>before, 1 hour and 3 hours post beverage</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>% Change in Blood Pressure (mmHg)</measure>
    <time_frame>before, 1 hour and 3 hours post beverage</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>% Change in Brain Connectivity (network degree)</measure>
    <time_frame>1 hour and 3 hours post beverage</time_frame>
    <description>Measures of functional brain connectivity based on resting-state functional magnetic resonance imaging.</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">6</enrollment>
  <condition>Caffeine</condition>
  <condition>Flavonoids</condition>
  <arm_group>
    <arm_group_label>low theobromine &amp; low caffeine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drink 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>low theobromine &amp; high caffeine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drink 2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>high theobromine &amp; low caffeine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drink 3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no theobromine &amp; high caffeine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Drink 4</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High Caffeine</intervention_name>
    <arm_group_label>low theobromine &amp; high caffeine</arm_group_label>
    <arm_group_label>no theobromine &amp; high caffeine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Low caffeine</intervention_name>
    <arm_group_label>low theobromine &amp; low caffeine</arm_group_label>
    <arm_group_label>high theobromine &amp; low caffeine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High theobromine</intervention_name>
    <arm_group_label>high theobromine &amp; low caffeine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>low theobromine</intervention_name>
    <arm_group_label>low theobromine &amp; low caffeine</arm_group_label>
    <arm_group_label>low theobromine &amp; high caffeine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>No theobromine</intervention_name>
    <arm_group_label>no theobromine &amp; high caffeine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consume 200-600 mg caffeine daily

          -  Willing and capable of signing the informed consent

          -  Willing to attend 4 testing sessions that will take 4-6 hours each AND will be at
             least 7 days apart

          -  Willing to abstain from caffeine for 24 hours before each testing session

          -  Willing to and able to have MRIs

        Exclusion Criteria:

          -  As determined from the medical screening session

               -  active neurological dysfunction (such as a major Axis I psychopathology,
                  Alzheimer's disease, Parkinson's disease, prior history of stroke, epilepsy, or
                  serious central nervous system (CNS) trauma)

               -  attention deficit hyperactivity disorder (ADHD)

               -  migraines

               -  hypertension

               -  diabetes

               -  peripheral vascular disease

               -  taking vasoactive medications (such as anti-hypertensive medications)

               -  depression that has not been on a stable medical treatment for at least 4 weeks

          -  Pregnancy

          -  Color blindness

          -  Allergy to chocolate, peanuts, tree nuts, egg, soy, mike, wheat

          -  Individuals who are or potentially may be cognitively or psychologically impaired, or
             who otherwise have a limited capacity to provide consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul J. Laurienti, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 13, 2013</study_first_submitted>
  <study_first_submitted_qc>August 14, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2013</study_first_posted>
  <last_update_submitted>November 2, 2017</last_update_submitted>
  <last_update_submitted_qc>November 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Caffeine</keyword>
  <keyword>Flavonoids</keyword>
  <keyword>MRI</keyword>
  <keyword>Brain blood flow</keyword>
  <keyword>Cognition</keyword>
  <keyword>Perfusion</keyword>
  <keyword>Resting functional magnetic resonance imaging (fMRI)</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caffeine</mesh_term>
    <mesh_term>Theobromine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

